Trials / Terminated
TerminatedNCT01433328
Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Jewish General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Treprostinil subcutaneous (under the skin) infusion is a very good medication for treating pulmonary arterial hypertension but infusion site pain may be very severe in some patients. The investigators plan to treat patients receiving treprostinil with a subcutaneous infusion of lidocaine (a local anesthestic) to treat the pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine | Lidocaine |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-03-01
- Completion
- 2012-04-01
- First posted
- 2011-09-13
- Last updated
- 2023-02-01
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01433328. Inclusion in this directory is not an endorsement.